Peptide record

TPDB18507

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
78 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB18507
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia ACP740 _ACP240 Antifungipept APD_complete APD_hemolytic
standard
No
A 78-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from Peptipedia, ACP740 _ACP240, Antifungipept, and other sources, with an available 3D structural model.
Sequence
DAECEICKFVIQQVEAFIESNHSQAEIQKELNKLCSSVPSITQTCLSIARMVPYIIKKLEEHNSPGQVCQGLHLCKSS
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C376H613N103O119S7
W
S
8705.04
5.82
10
9
27
-2
1.36
-0.128
93.72
Mammalian: 1.1 hour Yeast: 3 min E.coli: >10 hour
1865
0.21
28
Residue Composition
number
4
A
1
R
3
N
1
D
6
C
8
E
7
Q
2
G
3
H
8
I
6
L
6
K
1
M
2
F
3
P
9
S
2
T
0
W
1
Y
5
V
Amino Acid Distribution
A: 4 R: 1 N: 3 D: 1 C: 6 E: 8 Q: 7 G: 2 H: 3 I: 8 L: 6 K: 6 M: 1 F: 2 P: 3 S: 9 T: 2 W: 0 Y: 1 V: 5
Chemical Descriptors
78 reviewed residue count
C376H613N103O119S7 sequence-only estimate (linear, free termini)
8705.04 sequence-only estimate (linear, free termini)
5.82 sequence-only estimate (linear, free termini)
-2 sequence-only estimate (linear, free termini)
1.36 sequence-only estimate (linear, free termini)
-0.128 sequence-only estimate (linear, free termini)
Evidence Records 5 records
Evidence 1 Activity

Activity

MIC
Antibacterial
>10 µM

Target

B. subtilis and E-coli D31

Source & Reference

NA

Other

Active against B. subtilis and E-coli D31 (MIC >10 uM).
Evidence 2 Activity

Activity

MIC
Antifungal
>10 µM

Target

B. subtilis and E-coli D31

Source & Reference

Antifungipept

Other

Active against B. subtilis and E-coli D31 (MIC >10 uM).
Evidence 3 Activity

Activity

MIC
Antiparasitic
>10 µM

Target

B. subtilis and E-coli D31

Source & Reference

NA

Other

Active against B. subtilis and E-coli D31 (MIC >10 uM).
Evidence 4 Activity

Activity

MIC
Antiviral
>10 µM

Target

B. subtilis and E-coli D31

Source & Reference

NA

Other

Active against B. subtilis and E-coli D31 (MIC >10 uM).
Evidence 5 Hemolysis

Source & Reference

APD_complete APD_hemolytic
APD_complete APD_hemolytic

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.